SEC Form 4 · accession 0001478916-26-000012
First Tracks Biotherapeutics, Inc. · TRAX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P. Schmid
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002091349
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2026 | M | 6,030 | $0.00 | A | 37,652 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Jun 15, 2026 | M | 6,030 | D | — | — | Common Stock | 6,030 | 0 | D |
Explanation of responses
- F1Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- F2The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.